Impact of left ventricular hypertrophy on troponin release during acute myocardial infarction: New insights from a comprehensive translational study

Journal of the American Heart Association

Volumn 4, Issue 1, 2015, Pages

  Fernández Jiménez, Rodrigo ^a,b   Silva, Jacobo ^b   Martínez Martínez, Sara ^a   López Maderuelo, Ma Dolores ^a   Nuno Ayala, Mario ^a   García Ruiz, José Manuel ^a,c   García Álvarez, Ana ^a,d   Fernández Friera, Leticia ^a,e   Pizarro, Tech Gonzalo ^a,f   García Prieto, Jaime ^a   Sanz Rosa, David ^a   López Martin, Gonzalo ^a   Fernández Ortiz, Antonio ^b   Macaya, Carlos ^b   Fuster, Valentin ^a,g   Redondo, Juan Miguel ^a   Ibanez, Borja ^a,b  

^a CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

^e Hospital Universitario HM Montepríncipe   (Spain)

^f UNIVERSIDAD EUROPEA DE MADRID   (Spain)

^g MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Creatine kinase; Hypertrophy; Magnetic resonance imaging; Myocardial infarction; Troponin

Indexed keywords

CREATINE KINASE; TROPONIN I; BIOLOGICAL MARKER; CREATINE KINASE MB;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; FEMALE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE CELL; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PIG; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN SECRETION; RECEIVER OPERATING CHARACTERISTIC; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TRANSLATIONAL RESEARCH; AGED; ANIMAL; BLOOD; CINE MAGNETIC RESONANCE IMAGING; DISEASE MODEL; ELECTROCARDIOGRAPHY; HEART LEFT VENTRICLE FUNCTION; HYPERTROPHY, LEFT VENTRICULAR; METABOLISM; MIDDLE AGED; MYOCARDIAL INFARCTION; PHYSIOLOGIC MONITORING; PROCEDURES; PROGNOSIS; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX;

AGED; ANIMALS; AREA UNDER CURVE; BIOMARKERS; CREATINE KINASE, MB FORM; DISEASE MODELS, ANIMAL; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; MYOCARDIAL INFARCTION; PROGNOSIS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; ROC CURVE; SEVERITY OF ILLNESS INDEX; SUS SCROFA; SWINE; TRANSLATIONAL MEDICAL RESEARCH; TROPONIN I; VENTRICULAR FUNCTION, LEFT;

EID: 85017330126     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.114.001218     Document Type: Article

References (52)

1. Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd RM. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation. 2001;104:1101-1107.
2. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet. 2001;357:21-28.
3. Younger JF, Plein S, Barth J, Ridgway JP, Ball SG, Greenwood JP. Troponin-I concentration 72 h after myocardial infarction correlates with infarct size and presence of microvascular obstruction. Heart. 2007;93:1547-1551.
4. Chia S, Senatore F, Raffel OC, Lee H, Wackers FJ, Jang IK. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2008;1:415-423.
5. Licka M, Zimmermann R, Zehelein J, Dengler TJ, Katus HA, Kubler W. Troponin T concentrations 72 hours after myocardial infarction as a serological estimate of infarct size. Heart. 2002;87:520-524.
6. Hackel DB, Reimer KA, Ideker RE, Mikat EM, Hartwell TD, Parker CB, Braunwald EB, Buja M, Gold HK, Jaffe AS, Muller JE, Raabe DS, Rude RE, Sobel BE, Stone PH, Roberts R, and the MILIS Study Group. Comparison of enzymatic and anatomic estimates of myocardial infarct size in man. Circulation. 1984;70:824-835.
7. Kelle S, Roes SD, Klein C, Kokocinski T, de Roos A, Fleck E, Bax JJ, Nagel E. Prognostic value of myocardial infarct size and contractile reserve using magnetic resonance imaging. J Am Coll Cardiol. 2009;54:1770-1777.
8. Heusch G. Cardioprotection: chances and challenges of its translation to the clinic. Lancet. 2013;381:166-175.
9. Leonardi S, Armstrong PW, Schulte PJ, Ohman EM, Newby LK. Implementation of standardized assessment and reporting of myocardial infarction in contemporary randomized controlled trials: a systematic review. Eur Heart J. 2013;34:894-902d.
10. Fernandez-Jimenez R, Lopez-Romero P, Suarez-Barrientos A, Garcia-Rubira JC, Fernandez-Ortiz A, Fuster V, Macaya C, Ibanez B. Troponin release overestimates infarct size in presence of left ventricular hypertrophy. J Am Coll Cardiol. 2012;60:640-641.
11. Drazner MH, Dries DL, Peshock RM, Cooper RS, Klassen C, Kazi F, Willett D, Victor RG. Left ventricular hypertrophy is more prevalent in blacks than whites in the general population: the Dallas Heart Study. Hypertension. 2005;46:124-129.
12. Ferrara AL, Vaccaro O, Cardoni O, Panarelli W, Laurenzi M, Zanchetti A. Is there a relationship between left ventricular mass and plasma glucose and lipids independent of body mass index? Results of the Gubbio Study. Nutr Metab Cardiovasc Dis. 2003;13:126-132.
13. Ibanez B, Macaya C, Sanchez-Brunete V, Pizarro G, Fernandez-Friera L, Mateos A, Fernandez-Ortiz A, Garcia-Ruiz JM, Garcia-Alvarez A, Iniguez A, Jimenez-Borreguero J, Lopez-Romero P, Fernandez-Jimenez R, Goicolea J, Ruiz-Mateos B, Bastante T, Arias M, Iglesias-Vazquez JA, Rodriguez MD, Escalera N, Acebal C, Cabrera JA, Valenciano J, Perez de Prado A, Fernandez-Campos MJ, Casado I, Garcia-Rubira JC, Garcia-Prieto J, Sanz-Rosa D, Cuellas C, Hernandez-Antolin R, Albarran A, Fernandez-Vazquez F, de la Torre-Hernandez JM, Pocock S, Sanz G, Fuster V. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the effect of metoprolol in cardioprotection during an acute myocardial infarction (METOCARD-CNIC) trial. Circulation. 2013;128:1495-1503.
14. Pizarro G, Fernandez-Friera L, Fuster V, Fernandez-Jimenez R, Garcia-Ruiz JM, Garcia-Alvarez A, Mateos A, Barreiro MV, Escalera N, Rodriguez MD, de Miguel A, Garcia-Lunar I, Parra-Fuertes JJ, Sanchez-Gonzalez J, Pardillos L, Nieto B, Jimenez A, Abejon R, Bastante T, Martinez de Vega V, Cabrera JA, Lopez-Melgar B, Guzman G, Garcia-Prieto J, Mirelis JG, Zamorano JL, Albarran A, Goicolea J, Escaned J, Pocock S, Iniguez A, Fernandez-Ortiz A, Sanchez-Brunete V, Macaya C, Ibanez B. Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: results from the METOCARD-CNIC trial (effect of metoprolol in cardioprotection during an acute myocardial infarction). J Am Coll Cardiol. 2014;63:2356-2362.
15. Ibanez B, Fuster V, Macaya C, Sanchez-Brunete V, Pizarro G, Lopez-Romero P, Mateos A, Jimenez-Borreguero J, Fernandez-Ortiz A, Sanz G, Fernandez-Friera L, Corral E, Barreiro MV, Ruiz-Mateos B, Goicolea J, Hernandez-Antolin R, Acebal C, Garcia-Rubira JC, Albarran A, Zamorano JL, Casado I, Valenciano J, Fernandez-Vazquez F, de la Torre JM, Perez de Prado A, Iglesias-Vazquez JA, Martinez-Tenorio P, Iniguez A. Study design for the "effect of metoprolol in cardioprotection during an acute myocardial infarction" (METOCARD-CNIC): a randomized, controlled parallel-group, observer-blinded clinical trial of early pre-reperfusion metoprolol administration in ST-segment elevation myocardial infarction. Am Heart J. 2012;164:473-480.e475.
16. Kim RJ, Albert TS, Wible JH, Elliott MD, Allen JC, Lee JC, Parker M, Napoli A, Judd RM. Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial. Circulation. 2008;117:629-637.
17. Du Bois D, Du Bois EF. Clinical calorimetry: tenth paper a formula to estimate the approximate surface area if height and weight be known. Arch Intern Med. 1916;XVII:863-871.
18. Thiele H, Kappl MJ, Conradi S, Niebauer J, Hambrecht R, Schuler G. Reproducibility of chronic and acute infarct size measurement by delayed enhancement-magnetic resonance imaging. J Am Coll Cardiol. 2006;47:1641-1645.
19. Ibanez B, Cimmino G, Prat-Gonzalez S, Vilahur G, Hutter R, Garcia MJ, Fuster V, Sanz J, Badimon L, Badimon JJ. The cardioprotection granted by metoprolol is restricted to its administration prior to coronary reperfusion. Int J Cardiol. 2011;147:428-432.
20. Ibanez B, Prat-Gonzalez S, Speidl WS, Vilahur G, Pinero A, Cimmino G, Garcia MJ, Fuster V, Sanz J, Badimon JJ. Early metoprolol administration before coronary reperfusion results in increased myocardial salvage: analysis of ischemic myocardium at risk using cardiac magnetic resonance. Circulation. 2007;115:2909-2916.
21. Brody S. A comparison of growth curves of man and other animals. Science. 1928;67:43-46.
22. Sharkey SW, Murakami MM, Smith SA, Apple FS. Canine myocardial creatine kinase isoenzymes after chronic coronary artery occlusion. Circulation. 1991;84:333-340.
23. Koerbin G, Abhayaratna WP, Potter JM, Apple FS, Jaffe AS, Ravalico TH, Hickman PE. Effect of population selection on 99th percentile values for a high sensitivity cardiac troponin I and T assays. Clin Biochem. 2013;46:1636-1643.
24. Boden H, Ahmed TA, Velders MA, van der Hoeven BL, Hoogslag GE, Bootsma M, le Cessie S, Cobbaert CM, Delgado V, van der Laarse A, Schalij MJ. Peak and fixed-time high-sensitive troponin for prediction of infarct size, impaired left ventricular function, and adverse outcomes in patients with first ST-segment elevation myocardial infarction receiving percutaneous coronary intervention. Am J Cardiol. 2013;111:1387-1393.
25. Hallen J. Troponin for the estimation of infarct size: what have we learned? Cardiology. 2012;121:204-212.
26. Tardif JC, Tanguay JF, Wright SS, Duchatelle V, Petroni T, Gregoire JC, Ibrahim R, Heinonen TM, Robb S, Bertrand OF, Cournoyer D, Johnson D, Mann J, Guertin MC, L'Allier PL. Effects of the P-selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention for non-ST-segment elevation myocardial infarction: results of the SELECT-ACS trial. J Am Coll Cardiol. 2013;61:2048-2055.
27. Carluccio E, Tommasi S, Bentivoglio M, Buccolieri M, Filippucci L, Prosciutti L, Corea L. Prognostic value of left ventricular hypertrophy and geometry in patients with a first, uncomplicated myocardial infarction. Int J Cardiol. 2000;74:177-183.
28. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001;345:479-486.
29. Trask RV, Billadello JJ. Tissue-specific distribution and developmental regulation of M and B creatine kinase mRNAs. Biochim Biophys Acta. 1990;1049:182-188.
30. Ingwall JS, Kramer MF, Fifer MA, Lorell BH, Shemin R, Grossman W, Allen PD. The creatine kinase system in normal and diseased human myocardium. N Engl J Med. 1985;313:1050-1054.
31. Jameel MN, Zhang J. Myocardial energetics in left ventricular hypertrophy. Curr Cardiol Rev. 2009;5:243-250.
32. Nascimben L, Ingwall JS, Pauletto P, Friedrich J, Gwathmey JK, Saks V, Pessina AC, Allen PD. Creatine kinase system in failing and nonfailing human myocardium. Circulation. 1996;94:1894-1901.
33. Smith SH, Kramer MF, Reis I, Bishop SP, Ingwall JS. Regional changes in creatine kinase and myocyte size in hypertensive and nonhypertensive cardiac hypertrophy. Circ Res. 1990;67:1334-1344.
34. Vatner DE, Ingwall JS. Effects of moderate pressure overload cardiac hypertrophy on the distribution of creatine kinase isozymes. Proc Soc Exp Biol Med. 1984;175:5-9.
35. Ye Y, Wang C, Zhang J, Cho YK, Gong G, Murakami Y, Bache RJ. Myocardial creatine kinase kinetics and isoform expression in hearts with severe LV hypertrophy. Am J Physiol Heart Circ Physiol. 2001;281:H376-H386.
36. Sherwood MW, Kristin Newby L. High-sensitivity troponin assays: evidence, indications, and reasonable use. J Am Heart Assoc. 2014;3:e000403 doi:10.1161/JAHA.113.000403.
37. Eggers KM, Lind L, Venge P, Lindahl B. Factors influencing the 99th percentile of cardiac troponin I evaluated in community-dwelling individuals at 70 and 75 years of age. Clin Chem. 2013;59:1068-1073.
38. Hamwi SM, Sharma AK, Weissman NJ, Goldstein SA, Apple S, Canos DA, Pinnow EE, Lindsay J. Troponin-I elevation in patients with increased left ventricular mass. Am J Cardiol. 2003;92:88-90.
39. McKie PM, Heublein DM, Scott CG, Gantzer ML, Mehta RA, Rodeheffer RJ, Redfield MM, Burnett JC Jr, Jaffe AS. Defining high-sensitivity cardiac troponin concentrations in the community. Clin Chem. 2013;59:1099-1107.
40. Xanthakis V, Larson MG, Wollert KC, Aragam J, Cheng S, Ho J, Coglianese E, Levy D, Colucci WS, Michael Felker G, Benjamin EJ, Januzzi JL, Wang TJ, Vasan RS. Association of novel biomarkers of cardiovascular stress with left ventricular hypertrophy and dysfunction: implications for screening. J Am Heart Assoc. 2013;2:e000399 doi: 10.1161/JAHA.113.000399.
41. de Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A, Hashim I, Berry JD, Das SR, Morrow DA, McGuire DK. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA. 2010;304:2503-2512.
42. Chin CWL, Shah ASV, McAllister DA, Joanna Cowell S, Alam S, Langrish JP, Strachan FE, Hunter AL, Maria Choy A, Lang CC, Walker S, Boon NA, Newby DE, Mills NL, Dweck MR. High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis. Eur Heart J. 2014;35(34):2312-2321. doi:10.1093/eurheartj/ehu189
43. Rosjo H, Andreassen J, Edvardsen T, Omland T. Prognostic usefulness of circulating high-sensitivity troponin T in aortic stenosis and relation to echocardiographic indexes of cardiac function and anatomy. Am J Cardiol. 2011;108:88-91.
44. Wolf RE, Graeber GM, Burge JR, DeShong JL, MacDonald JL, Zajtchuk R. Evaluation of serum creatine kinase and lactate dehydrogenase in experimental myocardial infarction, atriotomies, and thoracotomies. Ann Thorac Surg. 1986;41:378-386.
45. Bertinchant JP, Robert E, Polge A, Marty-Double C, Fabbro-Peray P, Poirey S, Aya G, Juan JM, Ledermann B, de la Coussaye JE, Dauzat M. Comparison of the diagnostic value of cardiac troponin I and T determinations for detecting early myocardial damage and the relationship with histological findings after isoprenaline-induced cardiac injury in rats. Clin Chim Acta. 2000;298:13-28.
46. Walker DB. Serum chemical biomarkers of cardiac injury for nonclinical safety testing. Toxicol Pathol. 2006;34:94-104.
47. Thoren-Tolling K, Jonsson L. Creatine kinase isoenzymes in serum of pigs having myocardial and skeletal muscle necrosis. Can J Comp Med. 1983;47:207-216.
48. Fredericks S, Merton GK, Lerena MJ, Heining P, Carter ND, Holt DW. Cardiac troponins and creatine kinase content of striated muscle in common laboratory animals. Clin Chim Acta. 2001;304:65-74.
49. Newby LK, Jesse RL, Babb JD, Christenson RH, De Fer TM, Diamond GA, Fesmire FM, Geraci SA, Gersh BJ, Larsen GC, Kaul S, McKay CR, Philippides GJ, Weintraub WS. ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on clinical expert consensus documents. J Am Coll Cardiol. 2012;60:2427-2463.
50. Apple FS, Murakami MM, Ler R, Walker D, York M. Analytical characteristics of commercial cardiac troponin I and T immunoassays in serum from rats, dogs, and monkeys with induced acute myocardial injury. Clin Chem. 2008;54:1982-1989.
51. O'Brien PJ, Smith DE, Knechtel TJ, Marchak MA, Pruimboom-Brees I, Brees DJ, Spratt DP, Archer FJ, Butler P, Potter AN, Provost JP, Richard J, Snyder PA, Reagan WJ. Cardiac troponin I is a sensitive, specific biomarker of cardiac injury in laboratory animals. Lab Anim. 2006;40:153-171.
52. O'Brien PJ, Landt Y, Ladenson JH. Differential reactivity of cardiac and skeletal muscle from various species in a cardiac troponin I immunoassay. Clin Chem. 1997;43:2333-2338.